These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37038941)

  • 1. Impact of emergency department management of isolated superficial vein thrombosis of the lower limbs: a secondary analysis of data from the ALTAMIRA study.
    Beddar Chaib F; Jiménez Hernández S; Pedrajas Navas JM; Lecumberri R; Guirado Torrecillas L; Alonso Valle H; Diego Roza S; Sendín Martín V; Rivera Núñez MA; Pedraza García J; Sánchez Díaz-Canel D; Ruiz Artacho P;
    Emergencias; 2023 Apr; 35(2):109-116. PubMed ID: 37038941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of isolated superficial vein thrombosis and diagnostictherapeutic management in Spanish hospital emergency departments: the ALTAMIRA study.
    Beddar Chaib F; Jiménez Hernández S; Pedrajas Navas JM; Carriel Mancilla J; Castro Arias L; Merlo Loranca M; Peiró Gómez A; Álvarez Márquez Á; Lozano Polo L; Sánchez Garrido-Lestache Á; Lecumberri R; Ruiz Artacho P;
    Emergencias; 2021 Dec; 33(6):433-440. PubMed ID: 34813190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT).
    Bauersachs R; Gerlach HE; Heinken A; Hoffmann U; Langer F; Noppeney T; Pittrow D; Klotsche J; Rabe E
    Eur J Vasc Endovasc Surg; 2021 Aug; 62(2):241-249. PubMed ID: 34210599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of Late Venous Thromboembolic Events After Acute Isolated Superficial Vein Thrombosis in Daily Practice: 12 Month Results of the INSIGHTS-SVT Study.
    Rabe E; Hoffmann U; Schimke A; Heinken A; Langer F; Noppeney T; Pittrow D; Klotsche J; Gerlach HE; Bauersachs R;
    Eur J Vasc Endovasc Surg; 2023 Nov; 66(5):697-704. PubMed ID: 37573936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis.
    Di Minno MN; Ambrosino P; Ambrosini F; Tremoli E; Di Minno G; Dentali F
    J Thromb Haemost; 2016 May; 14(5):964-72. PubMed ID: 26845754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study.
    Barco S; Pomero F; Di Minno MND; Tamborini Permunian E; Malato A; Pasca S; Barillari G; Fenoglio L; Siragusa S; Di Minno G; Ageno W; Dentali F
    J Thromb Haemost; 2017 Nov; 15(11):2176-2183. PubMed ID: 28871623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).
    Cosmi B; Filippini M; Tonti D; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Palareti G;
    J Thromb Haemost; 2012 Jun; 10(6):1026-35. PubMed ID: 22487001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of patients with venous thromboembolic disease in the emergency department and their medium-term prognosis: data from the ESPHERIA registry.
    Carriel Mancilla J; Jiménez Hernández S; Martín-Sánchez FJ; Jiménez D; Lecumberri R; Alonso Valle H; Beddar Chaib F; Ruiz-Artacho P;
    Emergencias; 2021 Abr; 33(2):107-114. PubMed ID: 33750051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study.
    Decousus H; Quéré I; Presles E; Becker F; Barrellier MT; Chanut M; Gillet JL; Guenneguez H; Leandri C; Mismetti P; Pichot O; Leizorovicz A;
    Ann Intern Med; 2010 Feb; 152(4):218-24. PubMed ID: 20157136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Concomitant Superficial Vein Thrombosis in Patients with Deep Vein Thrombosis of the Lower Limbs.
    Dubois-Silva Á; Barbagelata-López C; Piñeiro-Parga P; Francisco I; Falgá C; Tirado R; Suriñach JM; Vela JR; Mella C; Quere I; Siniscalchi C; Monreal M;
    Thromb Haemost; 2021 Dec; 121(12):1650-1659. PubMed ID: 33677826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum).
    Cosmi B; Filippini M; Campana F; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Legnani C; Palareti G;
    Thromb Res; 2014 Feb; 133(2):196-202. PubMed ID: 24365043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs.
    Decousus H; Frappé P; Accassat S; Bertoletti L; Buchmuller A; Seffert B; Merah A; Becker F; Queré I; Leizorovicz A
    Best Pract Res Clin Haematol; 2012 Sep; 25(3):275-84. PubMed ID: 22959544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urgent surgery versus anticoagulation for treatment of superficial vein thrombosis in patients with varicose veins.
    Casian D; Bzovii F; Culiuc V; Gutu E
    Vasa; 2022 May; 51(3):174-181. PubMed ID: 35418255
    [No Abstract]   [Full Text] [Related]  

  • 15. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How I treat superficial venous thrombosis.
    Kitchens CS
    Blood; 2011 Jan; 117(1):39-44. PubMed ID: 20980677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of superficial vein thrombosis].
    Frappé P; Bertoletti L; Moulin N; Décousus H
    Rev Prat; 2015 Feb; 65(2):204-7. PubMed ID: 25939224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin.
    Karathanos C; Kakkos SK; Georgiadis G; Ioannou C; Vasdekis S; Chatzis D; Latzios P; Giannoukas AD;
    Phlebology; 2023 Apr; 38(3):141-149. PubMed ID: 36461172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community-based study.
    Frappé P; Buchmuller-Cordier A; Bertoletti L; Bonithon-Kopp C; Couzan S; Lafond P; Leizorovicz A; Merah A; Presles E; Preynat P; Tardy B; Décousus H;
    J Thromb Haemost; 2014 Jun; 12(6):831-8. PubMed ID: 24679145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.